BioNTech invests billions in cancer therapy:
After the end of the Corona pandemic, things have become quiet around the vaccine manufacturer BioNTech ...
faz.net/aktuell/rhein-main/wirtschaft/biontech-investiert-milliarden-in-krebstherapie-accg-200264940.html
Story Details
| Last Updated | |
| Total Articles | 8 |
Main Topics
vaccine that transfects synthetic RNA, reprogramming cells to make foreign protein that stimulates an adaptive immune response
News on this topic
Paid articlePaywall Victory over the Corona pandemic: BioNTech gave the world hope five years ago: Corona cost millions of lives in the pandemic year of 2020. On December 2nd ...
mittelhessen.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/sieg-ueber-corona-biontech-gab-welt-vor-fuenf-jahren-hoffnung-5211328
Paid articlePaywall Victory over the coronavirus pandemic: BioNTech gave the world hope five years ago
wiesbadener-kurier.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/sieg-ueber-corona-biontech-gab-welt-vor-fuenf-jahren-hoffnung-5211328
Paid articlePaywall Victory over the Corona pandemic: BioNTech gave the world hope five years ago: Corona cost millions of lives in the pandemic year of 2020. On December 2nd ...
main-spitze.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/sieg-ueber-corona-biontech-gab-welt-vor-fuenf-jahren-hoffnung-5211328
More articles on this subject
Previous
Paid articlePaywall Victory over the Corona pandemic: Biontech gave the world hope five years ago: Corona cost millions of lives in the pandemic year 2020. On December 2nd ...
allgemeine-zeitung.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/sieg-ueber-corona-biontech-gab-welt-vor-fuenf-jahren-hoffnung-5211328
Paid articlePaywall Victory over the Corona pandemic: BioNTech gave the world hope five years ago: Corona cost millions of lives in the pandemic year of 2020. On December 2nd ...
echo-online.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/sieg-ueber-corona-biontech-gab-welt-vor-fuenf-jahren-hoffnung-5211328
Next
Similar to This
Previous
Barron's Nov 13
Paid articlePaywall BioNTech May Be the Next Moderna. Even if it Isn’t, the Stock Is a Buy.: BioNTech has multiple catalysts that could generate a rally of 35% for the stock.
barrons.com/articles/buy-biontech-stock-price-pick-a64ac494
DAX Forecast: Lower - | US Midterms, Bayer, Lufthansa, FMC, BioNTech, AMD, Apple, Palantir in Focus
deraktionaer.de/artikel/indizes/dax-prognose-tiefer-us-midterms-bayer-lufthansa-fmc-biontech-amd-apple-palantir-im-fokus-20431435.html
BioNTech with figures: Forecasts beaten - | the details: BioNTech exceeds expectations in Q3 2026 with adjusted earnings of €1.76 per share ...
deraktionaer.de/artikel/pharma-biotech/biontech-mit-zahlen-prognosen-geschlagen-die-details-20432098.html
OpinionBioNTech in Marburg: Plant closure as a warning signal: The BioNTech site in Marburg once helped to ramp up vaccine production during the pandemic ...
faz.net/aktuell/rhein-main/biontech-in-marburg-werksschliessung-als-warnsignal-201271676.html
Katalin Karikó on mRNA research and new cancer vaccines: The university put her belongings in the hallway; at 58, she was sent into retirement. Shortly afterward ...
faz.net/aktuell/feuilleton/debatten/katalin-kariko-ueber-mrna-forschung-und-neue-krebsimpfstoffe-accg-201083587.html
Paid articlePaywall Biotechnology: This is what the separation plan with the founders looks like at BioNTech
handelsblatt.com/unternehmen/industrie/biotechnologie-so-sieht-der-trennungsplan-bei-biontech-mit-den-gruendern-aus/100229675.html
Paid articlePaywall BioNTech: Tight race for new "super" cancer drug: Cancer patients, doctors, and the stock market are watching a new class of tumor drugs with bated breath ...
echo-online.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/biontech-kopf-an-kopf-rennen-um-super-krebsmedikament-5732517
BioNTech: From pandemic hero to problem case: The Mainz-based company is closing locations and cutting thousands of jobs. The pandemic hero has become a problem ...
telepolis.de/article/BioNTech-Vom-Pandemie-Helden-zum-Problemfall-11298720.html
Bayer sues BioNTech and Pfizer over coronavirus vaccines: Did the manufacturers copy an old technology from Bayer subsidiary Monsanto? Bayer is now suing for ...
faz.net/aktuell/wirtschaft/unternehmen/bayer-verklagt-biontech-und-pfizer-wegen-corona-impfstoffen-accg-200415035.html
Moderna CEO: "The past two years haven't been fun": The biotechnology company sees itself back on track after a difficult period. CEO Stéphane Bancel reveals ...
faz.net/aktuell/wirtschaft/unternehmen/moderna-chef-die-vergangenen-zwei-jahre-waren-nicht-lustig-110791855.html
Corona vaccine partner Pfizer sells all BioNTech shares - | what's going on?: During the Corona pandemic, it was a brilliant vaccine partnership ...
allgemeine-zeitung.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/partner-pfizer-stoesst-alle-biontech-aktien-ab-was-ist-los-5158281
Paid articlePaywall BioNTech launches major video campaign for at-risk groups regarding COVID-19 vaccination
mittelhessen.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/biontech-faehrt-grosse-video-kampagne-zu-corona-impfung-5111619
Paid articlePaywall Biontech boss turns 60 - | the boy who wants to beat cancer: The "Lightspeed Project" of the first coronavirus vaccine catapults Ugur Sahin to the medical ...
mittelhessen.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/biontech-chef-wird-60-der-junge-der-krebs-besiegen-will-4993255
Trump minister Kennedy cuts large sums for certain vaccines: US Secretary of Health and Human Services Robert F. Kennedy Jr. is a vaccination sceptic ...
fr.de/politik/trump-minister-kennedy-streicht-hohe-summen-fuer-bestimmte-impfstoffe-zr-93870850.html
Pharma industry: Biontech halves loss - cancer strategy picks up speed: Biontech more than doubled its turnover in the second quarter. The company plans to spend ...
handelsblatt.com/unternehmen/industrie/pharmaindustrie-biontech-halbiert-verlust-krebsstrategie-nimmt-fahrt-auf/100146054.html
Key FactsBiontech Boosts Growth with Cancer Strategy and Deals
Aug 4, 2025 · Reading time: ~45 sec.
Summary created with AI assistance · Source: handelsblatt.com
Summary created with AI assistance · Source: handelsblatt.com
- Biontech doubled its revenue to €260.8 million in Q2 and reduced its net loss to €386.6 million.
- The company is refocusing on oncology, strengthened by a partnership with Bristol Myers Squibb and the planned acquisition of Curevac.
- Over 20 studies involving BNT327 across various tumors are underway, with a pivotal breast cancer phase-3 study starting this year.
- Revenue is forecasted to decline in 2025 while R&D spending is expected to increase to as much as €2.8 billion.
We continue to invest significantly in the implementation of our strategy, and our operational and financial measures are showing initial tangible results.— CFO Ramón Zapata discusses Biontech's progress in cancer research.
Biontech vs. Moderna: Investors' favorite: Biontech and Moderna made billions in profits with mRNA vaccines during the pandemic. The boom business has since ...
businessinsider.de/bi/biontech-vs-moderna-das-ist-der-favorit-der-investoren/
Biontech advances cancer therapies: Following the success of its coronavirus vaccines, the Mainz-based mRNA pioneer is now investing a lot of money in the ...
faz.net/aktuell/wirtschaft/unternehmen/biontech-treibt-krebstherapien-voran-110457280.html
Corona consequences: Another lawsuit against Biontech dismissed due to possible vaccine damage
welt.de/regionales/hamburg/article254740592/Corona-Folgen-Erneut-Klage-gegen-Biontech-wegen-moeglicher-Impfschaeden-abgewiesen.html
Key FactsCourt Dismisses Lawsuit Against Biontech
Dec 2, 2024 · Reading time: ~30 sec.
Summary created with AI assistance · Source: welt.de
Summary created with AI assistance · Source: welt.de
- A doctor in Hamburg filed a lawsuit against Biontech due to health issues post three COVID vaccinations, but the court dismissed the case.
- The court ruled that the plaintiff did not provide sufficient medical evidence to connect her complaints with the Comirnaty vaccine.
- The physician sought damages and compensation but is now responsible for the legal costs.
- Around 100 similar lawsuits have been processed in Germany, with this case being another in a series of rejected claims.
Next